New insights into the etiological pathogenesis of Peyronie's disease

被引:1
作者
Hauck, EW [1 ]
Hauptmann, A [1 ]
Haag, SM [1 ]
Weidner, W [1 ]
机构
[1] Univ Giessen, Klin & Poliklin Urol & Kinderurol, D-35385 Giessen, Germany
关键词
Peyronie's disease; etiological pathogenesis; HLA-system; TGF-beta; NO/ROS; cell culture; cytogenetic instability;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This paper reviews the current knowledge of the etiological pathogenesis of Peyronie's disease. De la Peyronie himself supposed a connection with venereal diseases. Herein, infectious, traumatic, autoimmune and genetic causes are discussed. An important hypothesis is that the recurrent microtraumatisation of the tunica albuginea during sexual intercourse leads to small lesions that activate processes of wound healing and development of fibrotic plaque. According to recent data, an association with the antigens of the HLA-system could be ruled out. Transforming growth factor beta (TGF-beta) seems to have an important impact due to its increased expression in the plaque. Furthermore it is possible to induce a condition similar to Peyronie's disease by intratunical injection of cytomodulin - a substance with TGF-beta-like activity - in an animal model. As in other fibrotic diseases, an imbalance between nitric oxide (NO) and reactive oxygen species (ROS) seems to be of importance. The most important new insights were gained from cell-culture models in which increased expression of basic fibroblast growth factor (bFGF), as well as a change in cell cycle regulation (p53) and cytogenetic instability were observed.
引用
收藏
页码:387 / 391
页数:5
相关论文
共 50 条
  • [41] The impact of Peyronie's disease on couples
    Thach, Sodara
    Pommier, Benjamin
    Soulier, Victor
    FRENCH JOURNAL OF UROLOGY, 2024, 34 (04):
  • [42] Injectable therapy for Peyronie's disease
    Chong, Weiliang
    Tan, Ronny Ban Wei
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (03) : 310 - 317
  • [43] Implant surgery in Peyronie's disease
    Marzi, M
    Zucchi, A
    Lombi, R
    Micheli, C
    Porena, M
    UROLOGIA INTERNATIONALIS, 1997, 58 (02) : 113 - 116
  • [44] SURGICAL TREATMENT OF PEYRONIE'S DISEASE
    Kadioglu, Ates
    Akman, Tolga
    Sanli, Oner
    Gurkan, Levent
    Cakan, Murat
    Celtik, Murat
    TURKISH JOURNAL OF UROLOGY, 2006, 32 (01): : 51 - 64
  • [45] Surgical Management of Peyronie's Disease
    Zaid, Uwais B.
    Alwaal, Amjad
    Zhang, Xiaoyu
    Lue, Tom F.
    CURRENT UROLOGY REPORTS, 2014, 15 (10)
  • [46] Plication Surgery for Peyronie’s Disease
    Giulio Garaffa
    Vincenzo Gentile
    Gabriele Antonini
    Amr Abdel Raheem
    David J. Ralph
    Current Sexual Health Reports, 2014, 6 (1) : 50 - 55
  • [47] Treatment of Peyronie's disease in 2009
    Morel-Journel, Nicolas
    Paparel, P.
    Ruffion, Alain
    Courtois, F.
    Leriche, A.
    PROGRES EN UROLOGIE, 2009, 19 (03): : F98 - F103
  • [48] Radiation Therapy in Peyronie's Disease
    Mulhall, John P.
    Hall, Matthew
    Broderick, Gregory A.
    Incrocci, Luca
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 (05) : 1435 - 1441
  • [49] Drugs of the future for Peyronie's disease
    Gur, Serap
    Kadowitz, Philip J.
    Hellstrom, Wayne J. G.
    MEDICAL HYPOTHESES, 2012, 78 (02) : 305 - 311
  • [50] Is high levels of vitamin D a new risk factor for Peyronie's disease?
    Canat, Halil Lutfi
    Can, Osman
    Ozbir, Sait
    Cakir, Suleyman Sami
    Culha, Mehmet Gokhan
    Bayraktarli, Recep Yilmaz
    Atalay, Hasan Anil
    ANDROLOGIA, 2019, 51 (09)